4//SEC Filing
Ajer Jeffrey Robert 4
Accession 0001567619-23-005283
CIK 0001048477other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 9:16 PM ET
Size
9.7 KB
Accession
0001567619-23-005283
Insider Transaction Report
Form 4
Ajer Jeffrey Robert
SVP, Chief Commercial Of
Transactions
- Award
Common Stock
2023-03-15+10,110→ 89,967 total - Tax Payment
Common Stock
2023-03-15$87.74/sh−3,971$348,416→ 85,996 total - Tax Payment
Common Stock
2023-03-16$93.41/sh−20,510$1,915,839→ 65,486 total - Award
Stock Option (Right to buy Common Stock)
2023-03-15+23,070→ 23,070 totalExercise: $87.74From: 2024-03-15Exp: 2033-03-14→ Common Stock (23,070 underlying)
Footnotes (2)
- [F1]Restricted stock units granted on March 15, 2023. Price not applicable.
- [F2]Option grant vests 12/48th on March 15, 2024 and 1/48th on the 15th day of each month thereafter.
Documents
Issuer
BIOMARIN PHARMACEUTICAL INC
CIK 0001048477
Entity typeother
Related Parties
1- filerCIK 0001557533
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 9:16 PM ET
- Size
- 9.7 KB